About the Company
Our client is a confidential, early-stage biotechnology company developing Cell Therapy targeting a major unmet need in an underserved patient population. The company is advancing its lead candidate toward first-in-human (FIH) clinical trials, with the goal of achieving early clinical proof of concept in both the US and EU.
The therapy has demonstrated meaningful outcomes in precli...
